Isolation of a carbapenem-resistant M. morganii co-producing ndm and armA, indicating genetic transfer risks.
Abstract Background Morganella morganii is intrinsically resistant to a wide range of antibiotics and is increasingly being reported worldwide. Methods A total of five M. morganii isolates were obtained from five patients at three hospitals in Myanmar between Sept. 2023 and Oct. 2024. Minimum inhibitory concentrations (MICs) were determined using the broth microdilution method. Genomic DNA was extracted and sequenced on the next generation sequencer. Drug-resistant factors were determined and the genetic environments surrounding carbapenemase and 16S rRNA methylase genes were analyzed. A phylogenetic tree was constructed using forty-six M. morganii subsp. morganii genome sequences, including the five Myanmar. Results One isolate harbored both blaNDM−1 and armA. This isolate was resistant to imipenem (MIC: 16 ug/ml) but susceptible to meropenem (MIC: 1 ug/ml). Whole genome sequencing revealed that blaNDM−1 and armA were located in close proximity on the chromosome of M. morganii strain YGH122, with the genetic region flanked by the two IS26 elements. Twenty-four strains deposited in GenBank carry the identical IS26-flanked genetic structure. Conclusions This is the first report of a clinical M. morganii isolate coharboring blaNDM−1 and armA in Myanmar. These genes located on chromosome with the genetic region flanked by the two IS26 elements. The presence of this structure suggests the possibility of horizontal co-transfer of these resistance genes from other Enterobacterales, such as Escherichia coli and Klebsiella pneumoniae.
No takes yet. Share an insight, caveat, or question.
Kirikae et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: